Results 121 to 130 of about 4,011 (178)

Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy. [PDF]

Adv Ther
Lachant D, Raina A, Krishnan M, Sood N, Balasubramanian V, Barbera JA, Kiely DG, Lee D, Wu B, Hwang S, Seaman S, Broderick M, Elwing J.   +12 more
europepmc   +1 more source

Latin American expert opinion paper on the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease. [PDF]

Front Med (Lausanne)
Lescano A, Pulido Zamudio T, Conde Camacho R, Caro FM, Espitia Hernández G, Fernandes CJCDS, García Cuéllar JA, Zagolín Blancaire M, Zayas Hernández N, Tobón M.   +9 more
europepmc   +1 more source

Clinical impact of treprostinil in neonates with persistent pulmonary hypertension refractory to inhaled nitric oxide: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Kim TH, Youn SE, Youn SE, Chung SH.
europepmc   +1 more source

Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review. [PDF]

Adv Ther
Elwing JM, Krishnan M, Parikh KS, Sargent T, Wu S, Benninger C, Doad G, Hill W, Oswald C, Bridge DC, O'Donovan P, Maranes LV, Miller C.   +12 more
europepmc   +1 more source

Advances in and Clinical Experience with Subcutaneous Infusion Pump Therapy for Pulmonary Arterial Hypertension. [PDF]

Adv Ther
LaRoy V, Roberts E, Mayeux J, Patzlaff N, Ismail R, Roberts K, Reed L, Stewart T, Whittenhall M, Wilson M.   +9 more
europepmc   +1 more source

Polycythemia Vera, Thrombophilia, CTEPH, Cerebral Venous Sinus Thrombosis and Vertebral Artery Occlusion: A Case-Illustrated Narrative Review of Competing Thrombotic and Hemorrhagic Risks. [PDF]

Life (Basel)
Bertici RA, Ridichie A, Bertici NS, Jianu DC, Munteanu G, Dan TF, Miron A, Mihnea L, Iacob N, Fira-Mladinescu O.   +9 more
europepmc   +1 more source

Treatment of Pulmonary Arterial Hypertension in Lithuania: Current Situation and Analysis of Survival of Patients Treated with Different Treatment Regimens. [PDF]

J Clin Med
Miliauskas S, Hoppenot D, Dimiene I, Grigoniene E, Gumbiene L, Nedzelskiene I, Vaizgela M, Ereminiene E.   +7 more
europepmc   +1 more source

Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Pelczar-Płachta W, Surmacz R, Bobkowski W.   +2 more
europepmc   +1 more source

Pulmonary Arterial Hypertension With a Secundum Atrial Septal Defect: "Treat-and-Repair" Strategy. [PDF]

JACC Case Rep
Haile H, Malkani K, Satish M, Yuan S, Kim L, Feldman D, Bergman G, Horn E, Karas M, Singh H.   +9 more
europepmc   +1 more source

Sotatercept administration in a young infant with severe pulmonary arterial hypertension: A case report. [PDF]

Front Pediatr
Rathakrishnan AV, Torgeson J, Beshish A, Bogenschutz MC, Balasubramaniam V, Lamers LJ.   +5 more
europepmc   +1 more source